By continuing to use the site you agree to our Privacy & Cookies policy

Crizotinib neuroblastoma study 'very promising'

A new way of using a drug called crizotinib in combination with a second class of drugs to treat neuroblastoma has shown “very promising” results, scientists said.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo